XU; Huaqiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for XU; Huaqiang.The latest application filed is for "fxr small molecule agonist and preparation method therefor and use thereof".

Company Profile

12.6.7

XU; Huaqiang - Pudong Shanghai CN
Xu; Huaqiang - Zhejiang CN
Xu; Huaqiang - Quzhou CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fxr Small Molecule Agonist And Preparation Method Therefor And Use Thereof App 20220213083 - XU; Huaqiang ; et al.	2022-07-07
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereof Grant 11,008,361 - Xi , et al. May 18, 2	2021-05-18
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate compound, and application thereof Grant 10,913,765 - Xi , et al. February 9, 2	2021-02-09
Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereof Grant 10,913,766 - Xi , et al. February 9, 2	2021-02-09
Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific delivery and use Grant 10,899,787 - Xi , et al. January 26, 2	2021-01-26
Cytarabine Prodrug Nucleoside Cyclic Phosphate Compound Based On Liverspecific Delivery And Use App 20200317711 - XI; Zhijian ; et al.	2020-10-08
Liver Specific Delivery-based Entecavir Prodrug, Nucleoside Cyclic Phosphate Compound, And Application Thereof App 20200317713 - XI; Zhijian ; et al.	2020-10-08
Liver Specific Delivery-based Gemcitabine Prodrug Nucleoside Cyclic Phosphate Compound, And Application Thereof App 20200317712 - XI; Zhijian ; et al.	2020-10-08
Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereof Grant 10,668,090 - Xi , et al.	2020-06-02
Hepatitis C virus inhibitor and uses thereof Grant 10,640,515 - Xi , et al.	2020-05-05
Liver-specific Delivery-based Anti-hepatitis C Prodrug Nucleoside Cyclo-phosphate Compound And Uses Thereof App 20200048299 - XI; Zhijian ; et al.	2020-02-13
Hepatitis C Virus Inhibitor And Uses Thereof App 20190135828 - XI; Zhijian ; et al.	2019-05-09
Liver Specific Delivery-based Antiviral Prodrug Nucleoside Cyclophosphate Compound And Uses Thereof App 20190125771 - XI; Zhijian ; et al.	2019-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.